{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T18:42:12Z","timestamp":1773427332520,"version":"3.50.1"},"publisher-location":"Cham","reference-count":57,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030556167","type":"print"},{"value":"9783030556174","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-55617-4_8","type":"book-chapter","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T03:39:08Z","timestamp":1612928348000},"page":"111-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Alain H.","family":"Rook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"7","key":"8_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ni1084","volume":"5","author":"SR Dillon","year":"2004","unstructured":"Dillon SR, Sprecher C, Hammond A et al (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice [published correction appears in Nat Immunol. 2005 Jan;6(1):114]. Nat Immunol 5(7):752\u2013760","journal-title":"Nat Immunol"},{"issue":"2","key":"8_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jaci.2005.10.046","volume":"117","author":"J Bilsborough","year":"2006","unstructured":"Bilsborough J, Leung DY, Maurer M et al (2006) IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis [published correction appears in J Allergy Clin Immunol. 2006;117(5):1124 . Boguniewcz, Mark [corrected to Boguniewicz, Mark]]. J Allergy Clin Immunol 117(2):418\u2013425","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2015.02.014","volume":"158","author":"F Cedeno-Laurent","year":"2015","unstructured":"Cedeno-Laurent F, Singer EM, Wysocka M et al (2015) Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clin Immunol 158(1):1\u20137","journal-title":"Clin Immunol"},{"issue":"2","key":"8_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jaci.2013.03.050","volume":"132","author":"B Stott","year":"2013","unstructured":"Stott B, Lavender P, Lehmann S, Pennino D, Durham S, Schmidt-Weber CB (2013) Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol 132(2):446\u201354.e5","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2340\/00015555-1191","volume":"92","author":"S Nobbe","year":"2012","unstructured":"Nobbe S, Dziunycz P, M\u00fchleisen B et al (2012) IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 92(1):24\u201328","journal-title":"Acta Derm Venereol"},{"issue":"21","key":"8_CR6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMc1704009","volume":"376","author":"T Ruzicka","year":"2017","unstructured":"Ruzicka T, Mihara R (2017) Anti-Interleukin-31 receptor A antibody for atopic dermatitis. N Engl J Med 376(21):2093","journal-title":"N Engl J Med"},{"issue":"12","key":"8_CR7","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/jid.2013.227","volume":"133","author":"EM Singer","year":"2013","unstructured":"Singer EM, Shin DB, Nattkemper LA et al (2013) IL-31 is produced by the malignant T-cell population in cutaneous T-cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol 133(12):2783\u20132785","journal-title":"J Invest Dermatol"},{"issue":"4","key":"8_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/cea.12875","volume":"47","author":"U Raap","year":"2017","unstructured":"Raap U, Gehring M, Kleiner S et al (2017) Human basophils are a source of\u2014and are differentially activated by\u2014IL-31. Clin Exp Allergy 47(4):499\u2013508","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"8_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2340\/00015555-2951","volume":"98","author":"U R\u00fcdrich","year":"2018","unstructured":"R\u00fcdrich U, Gehring M, Papakonstantinou E et al (2018) Eosinophils are a major source of Interleukin-31 in bullous pemphigoid. Acta Derm Venereol 98(8):766\u2013771","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"8_CR10","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jaci.2017.10.045","volume":"141","author":"IS Ba\u011fci","year":"2018","unstructured":"Ba\u011fci IS, Ruzicka T (2018) IL-31: a new key player in dermatology and beyond. J Allergy Clin Immunol 141(3):858\u2013866","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/leu.2014.291","volume":"29","author":"E Ferretti","year":"2015","unstructured":"Ferretti E, Tripodo C, Pagnan G et al (2015) The interleukin (IL)-31\/IL-31R axis contributes to tumor growth in human follicular lymphoma. Leukemia 29(4):958\u2013967","journal-title":"Leukemia"},{"issue":"7280","key":"8_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M et al (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463(7280):540\u2013544","journal-title":"Nature"},{"issue":"11","key":"8_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli LA, Sonnenberg GF, Abt MC et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12(11):1045\u20131054","journal-title":"Nat Immunol"},{"issue":"2","key":"8_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","volume":"40","author":"J Kim","year":"2019","unstructured":"Kim J, Kim BE, Leung DYM (2019) Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc 40(2):84\u201392","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"8_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3078","volume":"16","author":"Y Huang","year":"2015","unstructured":"Huang Y, Guo L, Qiu J et al (2015) IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells. Nat Immunol 16(2):161\u2013169","journal-title":"Nat Immunol"},{"issue":"1","key":"8_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP (2018) Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev 281(1):154\u2013168","journal-title":"Immunol Rev"},{"issue":"11","key":"8_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR (2016) Interleukin-33 in health and disease. Nat Rev Immunol 16(11):676\u2013689","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"8_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479\u2013490","journal-title":"Immunity"},{"issue":"2","key":"8_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2500\/aap.2018.38.4105","volume":"39","author":"AI Petra","year":"2018","unstructured":"Petra AI, Tsilioni I, Taracanova A, Katsarou-Katsari A, Theoharides TC (2018) Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and\/or immunoglobulin E. Allergy Asthma Proc 39(2):153\u2013160","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"8_CR20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1365-2133.2011.10487.x","volume":"165","author":"C Cornelissen","year":"2011","unstructured":"Cornelissen C, Brans R, Czaja K et al (2011) Ultraviolet B radiation and reactive oxygen species modulate interleukin-31 expression in T lymphocytes, monocytes and dendritic cells. Br J Dermatol 165(5):966\u2013975","journal-title":"Br J Dermatol"},{"issue":"2","key":"8_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4049\/jimmunol.1301836","volume":"193","author":"E Maier","year":"2014","unstructured":"Maier E, Werner D, Duschl A, Bohle B, Horejs-Hoeck J (2014) Human Th2 but not Th9 cells release IL-31 in a STAT6\/NF-\u03baB-dependent way. J Immunol 193(2):645\u2013654","journal-title":"J Immunol"},{"issue":"16","key":"8_CR22","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3390\/ijms20164053","volume":"20","author":"S Miake","year":"2019","unstructured":"Miake S, Tsuji G, Takemura M et al (2019) IL-4 augments IL-31\/IL-31 receptor alpha interaction leading to enhanced Ccl 17 and Ccl 22 production in dendritic cells: implications for atopic dermatitis. Int J Mol Sci 20(16):4053","journal-title":"Int J Mol Sci"},{"issue":"2","key":"8_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00005-014-0313-y","volume":"63","author":"M Sugaya","year":"2015","unstructured":"Sugaya M (2015) Chemokines and skin diseases. Arch Immunol Ther Exp 63(2):109\u2013115","journal-title":"Arch Immunol Ther Exp"},{"issue":"7","key":"8_CR24","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.4049\/jimmunol.179.7.4840","volume":"179","author":"LY Liu","year":"2007","unstructured":"Liu LY, Bates ME, Jarjour NN, Busse WW, Bertics PJ, Kelly EA (2007) Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha. J Immunol 179(7):4840\u20134848","journal-title":"J Immunol"},{"issue":"3","key":"8_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/jdv.12831","volume":"30","author":"S Altrichter","year":"2016","unstructured":"Altrichter S, Hawro T, H\u00e4nel K et al (2016) Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels. J Eur Acad Dermatol Venereol 30(3):454\u2013455","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5\u20136","key":"8_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","volume":"19","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W (2008) Structures and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 19(5\u20136):347\u2013356","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"8_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1189\/jlb.3MR0117-033R","volume":"102","author":"E Ferretti","year":"2017","unstructured":"Ferretti E, Corcione A, Pistoia V (2017) The IL-31\/IL-31 receptor axis: general features and role in tumor microenvironment. J Leukoc Biol 102(3):711\u2013717","journal-title":"J Leukoc Biol"},{"issue":"6","key":"8_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/all.12152","volume":"68","author":"S Kasraie","year":"2013","unstructured":"Kasraie S, Niebuhr M, Werfel T (2013) Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1\/2 and down-regulates IL-12p40 production in activated human macrophages. Allergy 68(6):739\u2013747","journal-title":"Allergy"},{"issue":"22","key":"8_CR29","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1111\/bph.12823","volume":"171","author":"K Kasutani","year":"2014","unstructured":"Kasutani K, Fujii E, Ohyama S et al (2014) Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol 171(22):5049\u20135058","journal-title":"Br J Pharmacol"},{"issue":"7","key":"8_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2340\/00015555-2417","volume":"96","author":"LA Nattkemper","year":"2016","unstructured":"Nattkemper LA, Martinez-Escala ME, Gelman AB et al (2016) Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin. Acta Derm Venereol 96(7):894\u2013898","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"8_CR31","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.4049\/jimmunol.0802459","volume":"182","author":"JG Perrigoue","year":"2009","unstructured":"Perrigoue JG, Zaph C, Guild K, Du Y, Artis D (2009) IL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infection. J Immunol 182(10):6088\u20136094","journal-title":"J Immunol"},{"issue":"3","key":"8_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","volume":"35","author":"JI Silverberg","year":"2017","unstructured":"Silverberg JI (2017) Public health burden and epidemiology of atopic dermatitis. Dermatol Clin 35(3):283\u2013289","journal-title":"Dermatol Clin"},{"issue":"2","key":"8_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.gene.2014.04.024","volume":"545","author":"YM Hussein","year":"2014","unstructured":"Hussein YM, Shalaby SM, Nassar A, Alzahrani SS, Alharbi AS, Nouh M (2014) Association between genes encoding components of the IL-4\/IL-4 receptor pathway and dermatitis in children. Gene 545(2):276\u2013281","journal-title":"Gene"},{"issue":"6","key":"8_CR34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","volume":"138","author":"H Esaki","year":"2016","unstructured":"Esaki H, Brunner PM, Renert-Yuval Y et al (2016) Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. J Allergy Clin Immunol 138(6):1639\u20131651","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8_CR35","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","volume":"123","author":"KE Nograles","year":"2009","unstructured":"Nograles KE, Zaba LC, Shemer A et al (2009) IL-22-producing \"T22\" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123(6):1244\u201352.e2","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"8_CR36","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","volume":"210","author":"M Salimi","year":"2013","unstructured":"Salimi M, Barlow JL, Saunders SP et al (2013) A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210(13):2939\u20132950","journal-title":"J Exp Med"},{"issue":"5","key":"8_CR37","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jaci.2017.12.1002","volume":"141","author":"J Meng","year":"2018","unstructured":"Meng J, Moriyama M, Feld M et al (2018) New mechanism underlying IL-31-induced atopic dermatitis. J Allergy Clin Immunol 141(5):1677\u20131689.e8","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaci.2011.10.042","volume":"129","author":"C Cornelissen","year":"2012","unstructured":"Cornelissen C, Marquardt Y, Czaja K et al (2012) IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol 129(2):426\u2013433.e4338","journal-title":"J Allergy Clin Immunol"},{"issue":"24","key":"8_CR39","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Guttman-Yassky E et al (2016) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375(24):2335\u20132348","journal-title":"N Engl J Med"},{"issue":"2","key":"8_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jmb.2016.12.005","volume":"429","author":"B Popovic","year":"2017","unstructured":"Popovic B, Breed J, Rees DG et al (2017) Structural characterisation reveals mechanism of IL-13-neutralising monoclonal antibody Tralokinumab as inhibition of binding to IL-13R\u03b11 and IL-13R\u03b12. J Mol Biol 429(2):208\u2013219","journal-title":"J Mol Biol"},{"issue":"1","key":"8_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4049\/jimmunol.1100467","volume":"187","author":"MT Kasaian","year":"2011","unstructured":"Kasaian MT, Raible D, Marquette K et al (2011) IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger activity of IL-13R\u03b12. J Immunol 187(1):561\u2013569","journal-title":"J Immunol"},{"issue":"4","key":"8_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","volume":"142","author":"K Kabashima","year":"2018","unstructured":"Kabashima K, Furue M, Hanifin JM et al (2018) Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study. J Allergy Clin Immunol 142(4):1121\u20131130.e7","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8_CR43","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","volume":"138","author":"LA Nattkemper","year":"2018","unstructured":"Nattkemper LA, Tey HL, Valdes-Rodriguez R et al (2018) The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Invest Dermatol 138(6):1311\u20131317","journal-title":"J Invest Dermatol"},{"issue":"6","key":"8_CR44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5114\/pdia.2015.56097","volume":"32","author":"M Czarnecka-Operacz","year":"2015","unstructured":"Czarnecka-Operacz M, Pola\u0144ska A, Klima\u0144ska M et al (2015) Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations. Postepy Dermatol Alergol 32(6):426\u2013430","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"8_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/bjd.16498","volume":"179","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Zeidi M, Bonciani D et al (2018) Itch in dermatomyositis: the role of increased skin interleukin-31. Br J Dermatol 179(3):669\u2013678","journal-title":"Br J Dermatol"},{"issue":"7","key":"8_CR46","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/jid.2015.106","volume":"135","author":"N Kunsleben","year":"2015","unstructured":"Kunsleben N, R\u00fcdrich U, Gehring M, Novak N, Kapp A, Raap U (2015) IL-31 induces chemotaxis, calcium mobilization, release of reactive oxygen species, and CCL26 in eosinophils, which are capable to release IL-31. J Invest Dermatol 135(7):1908\u20131911","journal-title":"J Invest Dermatol"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3389\/fimmu.2019.01383","volume":"10","author":"BF Gibbs","year":"2019","unstructured":"Gibbs BF, Patsinakidis N, Raap U (2019) Role of the pruritic cytokine IL-31 in autoimmune skin diseases. Front Immunol 10:1383","journal-title":"Front Immunol"},{"issue":"7","key":"8_CR48","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","volume":"88","author":"E Diamandidou","year":"1996","unstructured":"Diamandidou E, Cohen PR, Kurzrock R (1996) Mycosis fungoides and Sezary syndrome. Blood 88(7):2385\u20132409","journal-title":"Blood"},{"issue":"5","key":"8_CR49","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R, Kupper TS (2010) Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116(5):767\u2013771","journal-title":"Blood"},{"issue":"14","key":"8_CR50","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","volume":"19","author":"E Guenova","year":"2013","unstructured":"Guenova E, Watanabe R, Teague JE et al (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 19(14):3755\u20133763","journal-title":"Clin Cancer Res"},{"issue":"4","key":"8_CR51","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2008.08992.x","volume":"160","author":"F Sampogna","year":"2009","unstructured":"Sampogna F, Frontani M, Baliva G et al (2009) Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol 160(4):815\u2013822","journal-title":"Br J Dermatol"},{"issue":"10","key":"8_CR52","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/jdv.15075","volume":"32","author":"DJ Lewis","year":"2018","unstructured":"Lewis DJ, Huang S, Duvic M (2018) Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol 32(10):1652\u20131656","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8_CR53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","volume":"99","author":"BR Vowels","year":"1992","unstructured":"Vowels BR, Cassin M, Vonderheid EC, Rook AH (1992) Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99(1):90\u201394","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1067\/mjd.2001.109853","volume":"44","author":"KR Suchin","year":"2001","unstructured":"Suchin KR, Cassin M, Gottleib SL et al (2001) Increased interleukin 5 production in eosinophilic S\u00e9zary syndrome: regulation by interferon alfa and interleukin 12. J Am Acad Dermatol 44(1):28\u201332","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"8_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/vde.12047","volume":"24","author":"SB Cosgrove","year":"2013","unstructured":"Cosgrove SB, Wren JA, Cleaver DM et al (2013) Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol 24(5):479\u2013e114","journal-title":"Vet Dermatol"},{"issue":"6","key":"8_CR56","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/vde.12682","volume":"29","author":"CP Souza","year":"2018","unstructured":"Souza CP, Rosychuk RAW, Contreras ET, Schissler JR, Simpson AC (2018) A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Vet Dermatol 29(6):489\u2013e164","journal-title":"Vet Dermatol"},{"issue":"10","key":"8_CR57","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1600-0625.2010.01147.x","volume":"19","author":"M Feld","year":"2010","unstructured":"Feld M, Shpacovitch VM, Fastrich M, Cevikbas F, Steinhoff M (2010) Interferon-\u03b3 induces upregulation and activation of the interleukin-31 receptor in human dermal microvascular endothelial cells. Exp Dermatol 19(10):921\u2013923","journal-title":"Exp Dermatol"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-55617-4_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T22:09:54Z","timestamp":1697839794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-55617-4_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030556167","9783030556174"],"references-count":57,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-55617-4_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"10 February 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}